Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
8.61
+1.03 (13.59%)
At close: Mar 9, 2026, 4:00 PM EDT
9.05
+0.44 (5.11%)
After-hours: Mar 9, 2026, 7:53 PM EDT
Decoy Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5 | 3 | 3 | 3 | 22 | 22 | |
| Market Cap Growth | 137.21% | 3.58% | -26.55% | -84.43% | 3.40% | 40.82% | |
| Enterprise Value | -0 | -0 | -5 | -13 | -10 | 13 | |
| Last Close Price | 8.61 | 331.20 | 936.00 | 2203.20 | 17841.59 | 32759.97 | |
| PS Ratio | - | - | - | - | 12.17 | 4.14 | |
| PB Ratio | 0.16 | 1.75 | 0.48 | 0.34 | 0.58 | 0.98 | |
| P/TBV Ratio | 1.08 | 1.75 | 0.48 | 0.34 | 0.75 | 1.63 | |
| EV/Sales Ratio | - | - | - | - | - | 2.46 | |
| Debt / Equity Ratio | - | 0.15 | 0.06 | - | - | 0.02 | |
| Net Debt / Equity Ratio | -1.13 | -1.46 | -1.06 | -1.17 | -0.75 | -0.48 | |
| Net Debt / EBITDA Ratio | 0.86 | 0.39 | 0.44 | 0.53 | 2.28 | 1.37 | |
| Net Debt / FCF Ratio | 1.09 | 0.49 | 0.44 | 0.69 | 2.86 | 1.03 | |
| Asset Turnover | - | - | - | - | 0.06 | 0.27 | |
| Quick Ratio | 2.60 | 1.61 | 4.54 | 3.22 | 13.84 | 5.40 | |
| Current Ratio | 3.28 | 1.98 | 5.02 | 3.40 | 14.29 | 5.70 | |
| Return on Equity (ROE) | -139.55% | -164.02% | -160.07% | -128.73% | -41.94% | -44.91% | |
| Return on Assets (ROA) | -69.91% | -74.59% | -75.90% | -51.76% | -24.35% | -25.07% | |
| Return on Capital Employed (ROCE) | -131.10% | -379.30% | -243.90% | -221.20% | -33.10% | -35.10% | |
| Earnings Yield | -109.26% | -210.28% | -489.96% | -906.85% | -57.02% | -33.95% | |
| FCF Yield | -96.78% | -170.66% | -501.81% | -504.82% | -45.55% | -47.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.